Why Research and Bioinformatics Leaders Choose Syntes

  • Live operational context across clinical and research systems.
  • Enterprise knowledge graph modeling scientific relationships.
  • Dynamic context graphs linking patients, variants, outcomes.
  • Policy-aware AI agents within regulated research frameworks.
  • Explainable reasoning with full cross-system data lineage.
  • Bi-directional integration without disrupting existing pipelines.
  • Low-code platform for research and informatics teams
  • No-code configuration for research and data teams.

Book a Demo

What Syntes AI Enables

Cross-Domain Scientific Reasoning

Unify clinical phenotypes, genomic variants, lab results, and trial data into one contextual graph for advanced AI analysis.

Faster Hypothesis Validation

Agents traverse molecular, patient, and historical trial relationships to identify patterns and surface statistically relevant connections.

Reproducible, Traceable AI Decisions

Every insight ties back to source datasets, pipeline versions, documents, and relationships, supporting publication and regulatory review.

Real-Time Trial and Research Monitoring

Connect enrollment, safety signals, site data, protocol deviations, and lab results into a unified operational state.

Governed AI for Regulated Research

Agents simulate impact and enforce policy before modifying data, triggering workflows, or generating regulatory artifacts.

Why It Works for Research and Pharma Environments

Built for Scientific Data Diversity and Complexity

Structured, semi-structured, and unstructured research data coexist in a unified knowledge and context graph.

Context-Aware Agents, Not Generic Models

Agents reason over real relationships—gene ↔ pathway ↔ phenotype ↔ compound ↔ outcome—not isolated records.

Explainability Required for Regulatory Defense

Full lineage, version history, and traceable reasoning support FDA submissions and audit processes.

No Replatforming Required, Get Started Fast

Two-way connectors augment existing data lakes, warehouses, and bioinformatics pipelines without disruption.